AI Article Synopsis
- The text reviews existing literature on how preservatives in eye drops affect the ocular surface, particularly in glaucoma patients.
- It combines literature findings and expert opinions to offer guidance on assessing eye health and identifies patients who may benefit from preservative-free glaucoma treatments.
- The authors highlight a link between preservatives and ocular surface disease, noting that about 20% of patients requiring glaucoma eye drops may need preservative-free options, while also addressing common misconceptions about these therapies.
Article Abstract
Purpose: To review and summarize the available literature on the effect of preservatives on the eye, to provide practical guidance for the clinical assessment of the ocular surface in glaucoma patients, and to define patient populations that might benefit from preservative-free topical intraocular pressure (IOP)-lowering agents.
Methods: This manuscript is based on a combination of a literature review on preservatives and the eye and expert opinion from glaucoma specialists with an interest in ocular surface disease.
Results: There is an increasingly recognized association between eyedrop preservatives and ocular surface disease. Preservative-free therapy is now available for a wide range of active compounds, although there are still some misconceptions regarding their appropriate use. For patients treated topically for glaucoma or ocular hypertension, a rough estimate could be that 20% may need treatment with topical IOP-reducing agents that are free from preservatives.
Conclusion: This review provides an up-to-date account of the literature regarding preservatives and the eye, as well as suggestions and recommendations on to when to use preservative-free antiglaucoma treatment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.5301/ejo.5000270 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Efficacy and Safety of a Fixed-Dose Combination of Brinzolamide 1%/Timolol 0.5% vs. Dorzolamide 2%/Timolol 0.5% in Indian Patients With Primary Open-Angle Glaucoma or Ocular Hypertension: A Randomized Phase 3 Study.
Cureus
November 2024
Medical Affairs, Sun Pharma Laboratories Limited, Mumbai, IND.
Introduction Fixed-dose combinations (FDCs) have the potential in glaucoma management to improve efficacy due to the complementary mechanism of action of the drugs as well as compliance while reducing adverse effects by minimizing exposure to preservatives and the financial burden on the patients. FDC of brinzolamide/timolol has demonstrated efficacy and safety in multinational phase 3 studies in primary open-angle glaucoma (POAG) and ocular hypertension. However, efficacy and safety in the Indian population are not known.
View Article and Find Full Text PDFOcular hyperemia associated with topical glaucoma medication: understanding and differentiating clinical appearance and underlying mechanisms.
Expert Opin Drug Saf
December 2024
Tutkimusz Ltd, Solymár, Hungary.
Introduction: Adherence to therapy is fundamental for glaucoma management. Side effects of topical intraocular pressure (IOP)-lowering medications must be managed effectively to maintain adherence to the treatment plan and avoid disease progression. Ocular hyperemia is the most common side effect of topical IOP-lowering medications.
View Article and Find Full Text PDFConstruction of rhodamine-based fluorescent sensor for fast, on-site quantitative detection of hazardous salicylic acid in practical sample analysis.
Food Chem X
December 2024
State Key Laboratory of Green Pesticides, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for R&D of Fine Chemicals of Guizhou University, Guiyang 550025, China.
Salicylic acid (SA) is widely used in food storage, preservatives, additives, healthcare, and the pharmaceutical industry. However, various poisoning symptoms are frequently reported upon ingestion of a large amount of SA. Therefore, discovering new tools for sensing SA with fast, simple, and portable performance is imperative.
View Article and Find Full Text PDFA Soothing Lavender-Scented Electrospun Fibrous Eye Mask.
Molecules
November 2024
School of Materials and Chemistry, University of Shanghai for Science and Technology, Shanghai 200093, China.
Electrospinning technology has demonstrated extensive applications in biomedical engineering, energy storage, and environmental remediation. However, its utilization in the cosmetic industry remains relatively underexplored. To address the challenges associated with skin damage caused by preservatives and thickeners used for extending the shelf life of conventional products, a soothing lavender-scented electrospun fibrous eye mask with coaxial layers was developed using the electrospinning technique.
View Article and Find Full Text PDFOphthalmic Formulations for the Treatment of Allergic Conjunctivitis and Their Effect on the Ocular Surface: A Review of Safety and Tolerability Assessments in Clinical Trials.
J Clin Med
November 2024
Department of Cell Biology and Histology, School of Medicine and Nursing, University of the Basque Country, 48940 Leioa, Spain.
Allergic conjunctivitis (AC) is the most common allergic eye disorder. Antiallergic eyedrops are the first line of pharmacological treatment. However, the application of antiallergic eyedrops can potentially alter tear homeostasis and affect the ocular surface, which may result in iatrogenic diseases such as dye eye disease (DED).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!